Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced – BioSpace

eczemarelief
1 year ago
Share



Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced  BioSpace



Source link

Tags: Analysts, BioSpace, Declares, eczema, IIb, Nektar, Phase, RezpegBut, Unconvinced, win
Leave a Comment
Previous Article
Exeter Wins £3.3M Grant for Eczema Research – Mirage News
Next Article
Previewing the 2025 SDPA Annual Summer Dermatology Conference: What to Expect – Dermatology Times
Post Comment